Announcements Trials
Browse Landscape

Status

Unknown 2

Sponsor Class

UNKNOWN 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2929Neoplasms 2624Lung Neoplasms 1366Colorectal Neoplasms 1328Prostatic Neoplasms 1214Carcinoma, Non-Small-Cell Lung 1079Carcinoma, Hepatocellular 782Stomach Neoplasms 720Pancreatic Neoplasms 701Ovarian Neoplasms 586Colonic Neoplasms 533Uterine Cervical Neoplasms 497Head and Neck Neoplasms 495Rectal Neoplasms 472Melanoma 467Multiple Myeloma 463Esophageal Neoplasms 422Neoplasm Metastasis 418Brain Neoplasms 404Lymphoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 397Urinary Bladder Neoplasms 386Leukemia, Myeloid, Acute 385Leukemia 339Carcinoma, Renal Cell 329Liver Neoplasms 320Endometrial Neoplasms 319Hematologic Neoplasms 312Recurrence 298Disease 272

Interventions

palbociclib 1Fulvestrant 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Hormone Receptor Positive Advanced Breast Cancer × Clear all
NCT05000736 2022-04-29

CAPACITY

ChineseAMS

Unknown
600 enrolled
Breast

Hormone Receptor Positive Advanced Breast Cancer

NCT05343117 2022-04-26

Comparative Effectiveness of PAL Based-therapy as Initial ET Versus PAL Based-therapy After ChT for HR+/HER2- ABC

ChineseAMS

Unknown
400 enrolled
Breast

Hormone Receptor Positive Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡